Clinical and Biological Evaluation of the Novel CD30/CD16A Tetravalent Bispecific Antibody (AFM13) in Relapsed or Refractory CD30-Positive Lymphoma with Cutaneous Presentation: A Biomarker Phase Ib/IIa Study (NCT03192202)

Autor: Sawas, Ahmed, Elgedawe, Hager *, Vlad, George *, Lipschitz, Mikel *, Chen, Pei-Hsuan *, Rodig, Scott J, Lue, Jennifer Kimberly, Deng, Changchun, Amengual, Jennifer E, Abdul Hay, Maher, Khan, Karen *, Atkins, Laine E. *, Rada, Aishling M. *, Geskin, Larisa *, O'Connor, Owen A.
Zdroj: In Blood 29 November 2018 132 Supplement 1:2908-2908
Databáze: ScienceDirect